Intraarticular injection of high molecular weight hyaluronan for osteoarthritis of the knee - Prediction of effectiveness with biological markers

Journal of Rheumatology

Volumn 33, Issue 12, 2006, Pages 2527-2531

  Sugimoto, Haruo ^a   Yamada, Harumoto ^a   Terada, Nobuki ^a   Kanaji, Arihiko ^a   Kato, Shinichi ^a   Date, Hideki ^a   Ichinose, Hirofusa ^a   Miyazaki, Kyosuke ^b  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b SEIKAGAKU CORPORATION   (Japan)

Author keywords

Hyaluronan; Intraarticular injection therapy; Osteoarthritis; Prediction; Synovial fluid marker

Indexed keywords

AGGRECAN; BIOLOGICAL MARKER; CHONDROITIN 4 SULFATE; CHONDROITIN 6 SULFATE; HIGH MOLECULAR WEIGHT HYALURONAN; HYALURONIC ACID; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARTILAGE CELL; CLINICAL ARTICLE; DRUG EFFICACY; DRUG INDICATION; FEMALE; HUMAN; JAPAN ORTHOPEDIC ASSOCIATION SCORE; KNEE OSTEOARTHRITIS; KNEE RADIOGRAPHY; MALE; METABOLISM; PRIORITY JOURNAL; SCORING SYSTEM; SYMPTOMATOLOGY; SYNOVIAL FLUID; TREATMENT OUTCOME; VISUAL ANALOG SCALE;

ADJUVANTS, IMMUNOLOGIC; AGED; AGED, 80 AND OVER; AGGRECANS; ARTHROGRAPHY; BIOLOGICAL MARKERS; CHONDROITIN SULFATES; DISABILITY EVALUATION; FEMALE; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX; SYNOVIAL FLUID; TREATMENT OUTCOME;

EID: 33846054982     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomized, placebo-controlled clinical trial. Lancet 2001;357:251-6.
2. Richy F, Bruyere O, Ethgen O, Cucherat M, Henrotin Y, Reginster JY. Structural and symptomatic efficacy of glucosamine and chondroitin in knee osteoarthritis: a comprehensive meta-analysis. Arch Intern Med 2003;163:1514-22.
3. Dahl LB, Dahl IMS, Engstrom LA. Concentration and molecular weight of sodium hyaluronate in synovial fluid from patients with rheumatoid arthritis and other arthropathies. Ann Rheum Dis 1985;44:817-22.
4. Lisignoli G, Grassi F, Zini N, et al. Anti-Fas-induced apoptosis in chondrocytes reduced by hyaluronan: evidence for CD44 and CD54 (intercellular adhesion molecule 1) involvement. Arthritis Rheum 2001;44:1800-7.
5. Kikuchi T, Shinmei M. Effects of hyaluronan on proteoglycan metabolism of rabbit articular chondrocytes in cultures. Jpn J Rheumatol 1994;5:207-15.
6. Yasui T, Akatsuka M, Tobetto K, et al. Effects of hyaluronan on the production of stromelysin and tissue inhibitor of metalloproteinase-1 (TIMP-1) in bovine articular chondrocytes. Biomed Res 1992;13:343-8.
7. Kikuchi T, Yamada H, Fujikawa K. Effects of high molecular weight hyaluronan on the distribution and movement of proteoglycan around chondrocytes cultured in alginate beads. Osteoarthritis Cartilage 2001;9:351-6.
8. Takahashi K, Hashimoto S, Kubo T, Hirasawa Y, Lotz M, Amiel D. Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J Rheumatol 2000;27:1713-21.
9. Garnero P, Rousseau JC, Delmas PD. Molecular basis and clinical use of biochemical markers on bone, cartilage, and synovium in joint diseases. Arthritis Rheum 2000;43:953-68.
10. Campion GV, McCrae F, Schnitzer TJ, Lenz ME, Dieppe PA, Thonar EJ-MA. Levels of keratan sulfate in the serum and synovial fluid of patients with osteoarthritis of the knee. Arthritis Rheum 1991;34:1254-9.
11. Shinmei M, Miyauchi S, Machida A, Miyazaki K. Quantitation of chondroitin 4-sulfate and chondroitin 6-sulfate in pathologic joint fluid. Arthritis Rheum 1992;35:1304-8.
12. Lohmander LS, Hoerrner LA, Lark MW. Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum 1993;36:181-9.
13. Koshino T. Etiology, classifications and clinical findings of osteoarthritis of the knee [Japanese]. Ryumachi 1985;25:191-203.
14. The Japanese Orthopaedic Association Japanese Knee Society. Assessment criteria for knee diseases and treatments. Tokyo: Kanehara, 1994.
15. Guerne PA, Desgeorges A, Jaspar JM, et al. Effects of IL-6 and its soluble receptor on proteoglycan synthesis and NO release by human articular chondrocytes: comparison with IL-1. Modulation by dexamethasone. Matrix Biology 1999;18:253-60.
16. Peyron JG, Balazs LA. Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol 1974;22:731-6.
17. Altman RD. Intra-articular sodium hyaluronate in osteoarthritis of the knee. Semin Arthritis Rheum 2000;30:11-8.
18. Mankin HJ, Lippello L. The glycosaminoglycans of normal and arthritic cartilage. J Clin Invest 1971;50:1712-9.
19. Yamada H, Yoshihara Y, Kobayashi T, et al. Intra-articular injection therapy with high-molecular weight hyaluronan for osteoarthritis of the knee joint-Effects on joint fluid markers. Orthopaedics International Edition 1997;5:117-21.
20. Shinmei M, Ito K, Matsuyama S, Yoshihara Y, Matsuzawa K. Joint fluid carboxy-terminal type II procollagen peptide as a marker of cartilage collagen biosynthesis. Osteoarthritis Cartilage 1993;1:121-8.
21. Sugiyama S, Itokazu M, Suzuki Y, Shimizu K. Procollagen II C propeptide level in the synovial fluid as a predictor of radiographic progression in early knee osteoarthritis. Ann Rheum Dis 2003;62:27-32.
22. Namiki O, Kuriyama S, Maeda H, Sakamoto A. Biochemical analysis of synovial fluid and their alteration in intra-articular injection therapy of sodium hyaluronate in osteoarthritis. Joint Surgery 1994;21:131-7.
23. Uesaka S, Takeuchi T, Ide K, Yoshihara K, Nakayama Y, Shirai Y. Intra-articular injection therapy with sodium hyaluronate for osteoarthritis of the knee-Correlation between radiographic prognosis of osteoarthritis, joint markers and clinical evaluations. Joint Surgery 1999;26:106-12.
24. Yamada H, Miyauchi S, Hotta H, et al. Levels of chondroitin sulfate isomers in the synovial fluids from patients with hip osteoarthritis. J Orthop Science 1999;4:250-4.
25. Yamada H, Miyauchi S, Morita M, et al. Content and sulfation pattern of keratan sulfate in hip osteoarthritis using high performance liquid chromatography. J Rheumatol 2000;27:1721-4.
26. Kato S, Yamada H, Terada N, et al. Joint biomarkers in idiopathic femoral head osteonecrosis: comparison with hip osteoarthritis. J Rheumatol 2005;32:1518-23.